Rytary ER 36.25 MG-145 MG cap 100S

Ended Awarded Last action

Contract number
SPE2DR26FVYE9
Awardee
Awarding agency
Obligated
$113,557

Award facts

Contract value 100% obligated
$113,557.35 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $113,557.35 delivery order to Amerisourcebergen Drug Corp on January 6, 2026, for supply of RYTARY ER 36.25 mg-145 mg capsules (100-count units), with an ultimate completion date of January 7, 2026.

The order is issued under a firm fixed-price structure with no set-aside. Place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical procurement through the Defense Logistics Agency's medical supply chain.

Quick answers

Who was awarded contract SPE2DR26FVYE9?

SPE2DR26FVYE9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.

How much is contract SPE2DR26FVYE9 worth?

The government has obligated $113,557 on SPE2DR26FVYE9.

Is contract SPE2DR26FVYE9 an order under another contract?

Yes. SPE2DR26FVYE9 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.

Was contract SPE2DR26FVYE9 competed?

The extent of competition for SPE2DR26FVYE9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award